All Stories

  1. Investigation of human anthrax outbreak in Koraput district of Odisha, India
  2. SARS-CoV-2 seroprevalence in patients with autoimmune rheumatic diseases versus family controls: a multi-city cross-sectional survey
  3. Serosurveys to detect SARS-CoV-2 antibodies among high-risk groups in six urban cities of Odisha, India
  4. Vaccination coverage and breakthrough infections of COVID-19 during the second wave among staff of selected medical institutions in India
  5. Identification of potential inhibitor against CTX-M-3 and CTX-M-15 proteins: an in silico and in vitro study
  6. Community engagement and involvement in managing the COVID-19 pandemic among urban poor in low-and middle-income countries: a systematic scoping review and stakeholders mapping
  7. A Systematic Review of Water, Sanitation, and Hygiene for Urban Poor in Low- and Middle-Income Countries during the COVID-19 Pandemic through a Gendered Lens
  8. Analysis of the COVID-19 testing parameters and progression of the pandemic at the district level: findings from the ICMR Hundred Million Test (HMT) database during the first wave in India
  9. Identification of phytocompounds as newer antiviral drugs against COVID-19 through molecular docking and simulation based study
  10. Antibacterial and genotoxic activity of Bixa orellana, a folk medicine and food supplement against multidrug resistant clinical isolates
  11. Impact of smokeless cooking fuel use on health status of women in a rural setting of eastern India
  12. Assessment of socio-behavioural correlates and risk perceptions regarding anthrax disease in tribal communities of Odisha, Eastern India
  13. Resolution of Resilience: Empirical Findings on the Challenges Faced and the Mitigation Strategies Adopted by Community Health Workers (CHWs) to Provide Maternal and Child Health (MCH) Services during the COVID-19 Pandemic in the Context of Odisha, India
  14. Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India
  15. Discovery of phyto-compounds as novel inhibitors against NDM-1 and VIM-1 protein through virtual screening and molecular modelling
  16. Persistence of Antibodies Against Spike Glycoprotein of SARS-CoV-2 in Healthcare Workers Post Double Dose of BBV-152 and AZD1222 Vaccines
  17. Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al.
  18. Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
  19. COVID-19 in children in Odisha state, India: a retrospective review
  20. Breakthrough SARS‐CoV‐2 infections among BBV‐152 (COVAXIN®) and AZD1222 (COVISHIELD TM ) recipients: Report from the eastern state of India
  21. A systematic review and meta-analysis of screening and diagnostic accuracy for hearing loss among under-five children in South-Asian region
  22. IgG antibody response against nucleocapsid and spike protein post-SARS-CoV-2 infection
  23. SARS-CoV-2 seroprevalence among the general population and healthcare workers in India, December 2020–January 2021
  24. Pooled testing for SARS‐CoV‐2 infection in an automated high‐throughput platform
  25. Diagnostic accuracy comparison of three fully automated chemiluminescent immunoassay platforms for the detection of SARS-CoV-2 antibodies
  26. One Health approach for elimination of human anthrax in a tribal district of Odisha: Study protocol
  27. Serological surveys to inform SARS-CoV-2 epidemic curve: a cross-sectional study from Odisha, India
  28. Prevalence and molecular characterization of β-lactamase producers and fluoroquinolone resistant clinical isolates from North East India
  29. Seroprevalence of IgG antibody against SARS-CoV-2 among health care workers of anaesthesia departments from various hospital settings in India
  30. Sequence analysis of Indian SARS-CoV-2 isolates shows a stronger interaction of mutant receptor-binding domain with ACE2
  31. A qualitative exploratory study using One Health approach for developing an intervention package for elimination of human anthrax in an endemic district of Odisha, India
  32. Health system preparedness & community participation in Japanese encephalitis/acute encephalitis syndrome (JE/AES) prevention in a tribal district of Odisha, India
  33. Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys
  34. Saliva for diagnosis of SARS‐CoV‐2: First report from India
  35. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity
  36. SARS-CoV-2 IgG antibody responses in rt-PCR positive cases: first report from India
  37. Stakeholders’ Perspective for Improved Universal Newborn Hearing Screening Uptake in Odisha, India
  38. Saliva as a potential clinical specimen for diagnosis of SARS-CoV-2
  39. The Landscape of Anthrax Prevention and Control: Stakeholders’ Perceptive in Odisha, India
  40. Etiology of Non-Rotaviral Diarrhea in Hospitalized Children Under Five Years of Age
  41. Mapping of Health Technology Assessment (HTA) teaching and training initiatives: Landscape for evidence-based policy decisions in India
  42. Epidemiology of viral disease outbreaks in Odisha, India (2010–2019)
  43. Feasibility of Pooled Testing in a Fully Automated High Throughput Platform for Effective Management of SARS-CoV-2 in India
  44. Etiology of childhood diarrhoea among under five children and molecular analysis of antibiotic resistance in isolated enteric bacterial pathogens from a tertiary care hospital, Eastern Odisha, India
  45. Role of Natural Product in Modulation of Drug Transporters and New Delhi Metallo-β Lactamases
  46. Letters to the Editor
  47. A cross-sectional study on aetiology of diarrhoeal disease, India
  48. Green and ecofriendly synthesis of silver nanoparticles: Characterization, biocompatibility studies and gel formulation for treatment of infections in burns
  49. Vibrio cholerae O1 El Tor variant and emergence of Haitian ctxB variant in the strains isolated from South India
  50. Isolation of NDM-1-producing multidrug-resistant Pseudomonas putida from a paediatric case of acute gastroenteritis, India
  51. Transition Densities and Sample Frequency Spectra of Diffusion Processes with Selection and Variable Population Size
  52. Emergence of influenza A (H1N1) PDM09 in the remote Islands of India - A molecular approach
  53. Shewanella algae in acute gastroenteritis
  54. Multidrug-Resistant <i>Vibrio cholerae</i> O1 was Responsible for a Cholera Outbreak in 2013 in Bagalkot, North Karnataka
  55. Occult hepatitis B infection among individuals belonging to the aboriginal Nicobarese tribe of India
  56. Changing patterns and widening of antibiotic resistance inShigellaspp. over a decade (2000–2011), Andaman Islands, India
  57. Prevalence of Mutations in Basal Core Promoter and Precore Region of Hepatitis B Virus in Vaccinated and Nonvaccinated Individuals of the Aboriginal Nicobarese Tribe of Car Nicobar Island, India
  58. Emergence of New Delhi metallo-β-lactamase 1 (NDM-1) Producing and Multidrug Resistant Uropathogens Causing Urinary Tract Infections in Andaman Islands, India
  59. Shigellosis in Bay of Bengal Islands, India: clinical and seasonal patterns, surveillance of antibiotic susceptibility patterns, and molecular characterization of multidrug-resistant Shigella strains isolated during a 6-year period from 2006 to 2011
  60. Emergence of an Unusual Genotype of Rotavirus in Andaman and Nicobar Islands, India
  61. Emergence of Multidrug-Resistant Vibrio cholerae O1 Biotype El Tor in Port Blair, India
  62. High-risk HPV infection among the tribal and non-tribal women of the Andaman and Nicobar Islands, India
  63. Dengue: a newly emerging viral infection in Andaman and Nicobar Islands, India
  64. Isolation and molecular characterization of Chikungunya virus from the Andaman and Nicobar archipelago, India: evidence of an East, Central, and South African genotype
  65. H1N1 influenza A outbreak among the Nicobarese, an aboriginal tribe of the Andaman and Nicobar Islands, India
  66. Third-generation cephalosporin resistance in clinical isolate of Shigella sonnei in Andaman & Nicobar Islands, India
  67. Prevalence of the plasmid-mediated quinolone resistance determinants among clinical isolates of Shigella sp. in Andaman & Nicobar Islands, India
  68. Rapid Emergence of Third-Generation Cephalosporin Resistance in Shigella Sp. Isolated in Andaman and Nicobar Islands, India
  69. Acute Diarrhea in Children after 2004 Tsunami, Andaman Islands